Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.28 +6.67%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
